Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing 76 - 100 of 1,882
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

Not yet recruiting
  • Hematologic Malignancy
  • +5 more
  • autologous hematopoietic stem cells added to planned CAR T
  • Los Angeles, California
    Cedars-Sinai Medical Center
May 31, 2023

Management Plan Material Utilization Among Pharmacists in Japan

Not yet recruiting
  • Multiple Myeloma
  • No Intervention
  • (no location specified)
May 22, 2023

Real-world Usage of HyQvia in Multiple Myeloma Secondary

Not yet recruiting
  • Multiple Myeloma
  • Secondary Immunodeficiency (SID)
  • No Intervention
  • (no location specified)
May 19, 2023

Breast Cancer, Hodgkin Lymphoma, Kidney Cancer Trial (Assessment tool IA3-CP with SDoH, Assessment tool IA3-CP without SDoH)

Not yet recruiting
  • Breast Cancer
  • +9 more
  • Assessment tool IA3-CP with SDoH
  • Assessment tool IA3-CP without SDoH
  • (no location specified)
May 22, 2023

Examination of Trends in Multiple Myeloma Trial Patient

Not yet recruiting
  • Multiple Myeloma
    • (no location specified)
    May 19, 2023

    Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Discontinuation of maintenance treatment
    • Cork, Ireland
      Cork University Hospital
    May 10, 2023

    Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, VRD)

    Recruiting
    • Multiple Myeloma
    • anti-BCMA CAR-T
    • VRD
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    May 5, 2023

    Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, Selinexor-VRD)

    Recruiting
    • Multiple Myeloma
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    May 12, 2023

    Multiple Myeloma Trial in Roma, Rome (ATAC-seq and ChIP-seq)

    Recruiting
    • Multiple Myeloma
    • ATAC-seq and ChIP-seq
    • Roma, Italy
    • +1 more
    May 4, 2023

    Multiple Myeloma, Multiple Myeloma in Relapse Trial (Belantamab mafodotin, Venetoclax)

    Not yet recruiting
    • Multiple Myeloma
    • Multiple Myeloma in Relapse
    • Belantamab mafodotin, Venetoclax
    • (no location specified)
    May 10, 2023

    Multiple Myeloma Trial in Suzhou (Tocilizumab)

    Recruiting
    • Multiple Myeloma
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    May 3, 2023

    Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T)

    Recruiting
    • Multiple Myeloma
    • anti-BCMA CAR-T
    • Tianjin, Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    May 4, 2023

    Multiple Myeloma Trial in Augusta (Lenalidomide, Vitamin D - Intensified, Vitamin D - Therapeutic)

    Not yet recruiting
    • Multiple Myeloma
    • Augusta, Georgia
      Georgia Cancer Center at Augusta University
    Apr 26, 2023

    Biomarker for Infection Risk in CLL and MM

    Not yet recruiting
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Screening
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    May 3, 2023

    Multiple Myeloma, Smoldering Multiple Myeloma Trial in Oslo (TG01)

    Not yet recruiting
    • Multiple Myeloma
    • Smoldering Multiple Myeloma
    • TG01
    • Oslo, Norway
      Oslo Myeloma Center
    May 2, 2023

    Multiple Myeloma Trial in Shanghai (GC012F injection)

    Not yet recruiting
    • Multiple Myeloma
    • GC012F injection
    • Shanghai, Shanghai, China
      Shanghai Changzheng Hospital
    May 1, 2023

    Multiple Myeloma, Primary Plasma Cell Leukemia Trial in Shanghai (Experimental: CAR-T cells Infusion)

    Not yet recruiting
    • Multiple Myeloma
    • Primary Plasma Cell Leukemia
    • Experimental: CAR-T cells Infusion
    • Shanghai, China
      Shanghai Changzheng Hospital
    Apr 20, 2023

    Stem Cells Mobilization, colLection and Engraftment in Newly

    Recruiting
    • Multiple Myeloma
    • +3 more
    • Rome, Italy
      Fondazione Policlinico Universitario A.Gemelli IRCCS
    Apr 28, 2023

    Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in Cleveland (Multiple

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Multiple Myeloma M-Protein Analysis
    • Multiple Myeloma Knowledge Questionnaires
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Apr 26, 2023

    Corneal Findings in Patients Treated With Belantamab Mafodotin

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Belantamab mafodotin
    • (no location specified)
    Apr 25, 2023

    Multiple Myeloma Trial (Patient Reported Outcomes)

    Not yet recruiting
    • Multiple Myeloma
    • Patient Reported Outcomes
    • (no location specified)
    Apr 24, 2023

    Multiple Myeloma Trial (Linvoseltamab)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Apr 12, 2023

    Multiple Myeloma Trial in Worldwide (Iberdomide, Lenalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • Orange, California
    • +270 more
    Apr 11, 2023

    Fluoroquinolone Resistance Prevalence Study

    Recruiting
    • Multiple Myeloma
      • Washington, District of Columbia
      • +1 more
      Apr 10, 2023

      Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

      Not yet recruiting
      • Leukemia, Acute
      • +7 more
      • (no location specified)
      Apr 10, 2023